Repromune 4

This page contains information on Repromune 4 for veterinary use.
The information provided typically includes the following:
  • Repromune 4 Indications
  • Warnings and cautions for Repromune 4
  • Direction and dosage information for Repromune 4

Repromune 4

This treatment applies to the following species:
Manufacturer: Ceva Biomune

Bursal Disease-Newcastle Disease-Bronchitis-Reovirus Vaccine, Mass. Type, Killed Virus

U.S. Vet. Lic. No.: 368

Contents: REPROMUNE® 4 is an inactivated oil emulsion vaccine containing infectious bursal disease virus, Newcastle disease virus, infectious bronchitis viruses of the Mass. serotype (Holland strain and Mass. M41) and two reoviruses strain S1133 (a tenosynovitis pathotype) and strain 2408 (a malabsorption pathotype).

Repromune 4 Indications

The vaccine is indicated for use in healthy breeder replacement chickens and breeder hens against diseases caused by infectious bursal disease virus, Newcastle disease virus, infectious bronchitis virus and reovirus. Breeder vaccination provides maternal antibody to progeny of breeder hens for prevention of early exposure to bursal disease, tenosynovitis (viral arthritis) and malabsorption syndrome.

Dosage and Administration

Optimum results with REPROMUNE® 4 require that chickens are adequately primed with live infectious bursal disease vaccine, tenosynovitis vaccine and bronchitis vaccine of the Mass. type at least four weeks in advance of administration of the inactivated vaccine.

Vaccinate chickens with 0.5 mL (1/2 cc) per bird. The vaccine is to be administered by the subcutaneous route in the back of the neck, midway between the head and the body and in a direction away from the head. Do not inject into muscle or vertebrae.

Precaution(s): Store the vaccine at 35°-45°F (2°-7°C). Do not freeze.

Caution(s): This vaccine has undergone rigid potency, safety and purity tests and meets Biomune and USDA requirements.

Warning(s): Do not vaccinate with oil emulsion vaccine within 42 days before slaughter. Avoid injection of this vaccine into a human. Should accidental injection of a human occur, seek expert medical attention immediately since a serious localized reaction may result.

Presentation: 1,000 dose (500 mL) bottles.

NAC No.: 11290283

CEVA BIOMUNE
8906 ROSEHILL ROAD, LENEXA, KS, 66215
Telephone:   913-894-0230
Fax:   913-894-0236
Website:   www.ceva-us.com
Every effort has been made to ensure the accuracy of the Repromune 4 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-09-05

(web1)